Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I and II Study of PEG-Glucocerebrosidase in Patients With Type 1 or Type 3 Gaucher Disease

NCT00001410 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00001410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I and II Study of PEG-Glucocerebrosidase in Patients With Type 1 or Type 3 Gaucher Disease
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Completed
Start date
October 31, 1993
Completion date
December 31, 2001
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher's disease